Date
- 2026 (2)
- 2025 (137)
- 2024 (266)
- 2023 (133)
- 2022 (153)
- 2021 (74)
- 2020 (177)
- 2019 (227)
- 2018 (262)
- 2017 (310)
- 2016 (372)
- 2015 (314)
- 2014 (372)
- 2013 (284)
- 2012 (304)
- 2011 (299)
- 2010 (106)
- 2009 (76)
- 2008 (95)
- 2007 (93)
- 2006 (48)
- 2005 (34)
- 2004 (40)
- 2003 (33)
- 2002 (26)
- 2001 (25)
- 2000 (34)
- 1999 (10)
- 1998 (8)
- 1997 (5)
- 1996 (5)
- 1995 (2)
- 1994 (2)
- 1993 (1)
- 1992 (7)
- 1991 (34)
Sponsor content
4370 result(s) found, displaying 81 to 90
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAMADOL-RJIC SR tramadol hydrochloride 100 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAMADOL-TIH SR tramadol hydrochloride 150 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAMADOL-TIH SR tramadol hydrochloride 200 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAMADOL-RJIC SR tramadol hydrochloride 200 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAMADOL-TIH SR tramadol hydrochloride 100 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHELINUN melphalan (as hydrochloride) 200 mg powder for injection vial with diluent composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHELINUN melphalan (as hydrochloride) 50 mg powder for injection vial with diluent composite pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2025
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2025
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2025